Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need to know. Fact checked by Sarah Scott Within a week of Brian Hartnett and ...

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...

Federal health officials are reviewing the safety of two injectable drugs used to protect babies and toddlers from the RSV virus.

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

Recovering from respiratory syncytial virus often doesn't end when it's time to leave the hospital, even for younger adults.

An infection with respiratory syncytial virus (RSV) typically affects infants much harder than adults. While adults usually ...

The Ministry of Health, Wellness and Elderly Affairs informs the public that we are in the midst of the flu season, which ...

Objectives The common cold is the main cause of medical time loss in elite sport. Rapid diagnosis has been a challenge that may be amenable to molecular point-of-care testing (POCT). Methods We ...

This is read by an automated voice. Please report any issues or inconsistencies here. The leading cause of infant hospitalization, RSV can trigger severe pneumonia and lung infections. Health ...

This story was originally published in 2022; it has since been updated. It started with a tickle in your throat. Then, it evolved into congestion, and maybe a little cough. Perhaps you lost your voice ...